Ascend Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
AIM
GI
SAM
DRZID
Ascend Capital's DBD Position: Q2 2017 in Review
Ascend Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2017, closing a stake of 492,694 shares — an estimated $15.1M sold.
Ascend Capital first reported a position in DBD in Q4 2015 and held it in 6 quarters. The position peaked at $26M in Q1 2016. 235 funds tracked by Wall St. Rank hold DBD as of Q2 2017.
- Ascend Capital reported no remaining Diebold Nixdorf Incorporated position as of Q2 2017 after selling out during the quarter.
- Ascend Capital sold 492,694 Diebold Nixdorf Incorporated shares in Q2 2017, an estimated $15.1M.
- Ascend Capital first reported a position in Diebold Nixdorf Incorporated in Q4 2015 and held it in 6 quarters.
- Ascend Capital's Diebold Nixdorf Incorporated position peaked at $26M in Q1 2016.
- 235 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2017.
Based on Ascend Capital's 13F filing for Q2 2017, filed 11 Aug 2017.